{
 "PrintNo":"A8212","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-08-25T14:17:40.123906Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-08-25","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":1089,"Name":"Alicia Hyndman","Short":"HYNDMAN"}],
 "Title":"Limits the off label use of antipsychotic drugs on elderly patients with dementia",
 "Summary":"Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.",
 "LawSection":"Public Health Law","LawCode":"Add ยง280-d, Pub Health L; amd ยง6530, Ed L",
 "ActClause":"AN ACT to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct",
 "SameAsPrintNo":"S6462-2021"
}